EasyDay Edibles has launched its CoolMST Inhaler in Washington, D.C., putting a battery-free, heat-free THC delivery format on local dispensary shelves. Each canister dispenses 200 metered sprays at 5 mg of THC per press, according to the company, with no combustion, charging or heating coil involved.
For D.C. operators, the launch is less about one product than about a question every buyer is facing this year: how much shelf space should go to new formats that promise controlled, low-dose consumption, and how much proof should a vendor bring before getting it?
What EasyDay Is Selling
The device was developed with R2 Innovations Inc. of Centennial, Colorado, and is licensed nationally through Paradigm Partners and Brands of Fairfax, Virginia, which holds exclusive rights. EasyDay says the inhaler uses micelle technology to deliver a fast-acting, smoke-free experience and describes the product as multi-patented. The company has not published onset data or patent numbers with the announcement.
The launch extends EasyDay’s Up & Focus and Rest & Relax lines into a new format. Up & Focus is a citrus-flavored sativa option. Rest & Relax is a mint-flavored indica option with added CBN.
“We’re taking the spirit of our Up & Focus and Rest & Relax lineup beyond edibles and vapes,” said Alan Manstof, founder of EasyDay Edibles. He described the inhaler as a simple, discreet format that patients can carry easily.
Initial distribution includes Takoma Wellness Center and Cookies DC, with more locations to follow, the company said.
Why The D.C. Market Matters Here
D.C. is an unusual place to launch a premium, dose-controlled product. Licensed dispensaries have spent years competing with unlicensed shops operating under the District’s Initiative 71 “gifting” model, a fight Cannabis Professional covered as regulators began cracking down on unlicensed but “I-71 compliant” cannabis shops.
That competition shapes how a product like CoolMST gets sold. Licensed stores can’t win on price against operators who skip testing, licensing and taxes. They can win on what unlicensed shops can’t credibly offer: tested products, accurate labeling and staff who can explain a dose. A metered device with a stated milligram count per spray plays to that advantage, but only if the dose claims hold up and the budtender can back them.
Where This Fits In The Low-Dose Shift
CoolMST lands as dispensaries rethink their mix around controlled-dose formats. Cannabis Professional’s breakdown of how pre-rolls, THC beverages and low-dose products are reshaping dispensary inventory lays out the buying approach for these categories, and the same discipline applies here: decide what customer the product serves, what it replaces on the shelf and how you’ll know if it’s working.
The inhaler is aimed at a specific shopper: someone who wants faster onset than an edible without vaping or smoking. Whether that customer exists in volume at your store is the first thing to answer before placing an order.
What Changes On The Sales Floor
Metered dosing is the clearest selling point. At 5 mg per spray, a budtender can frame a starting dose the same way they would a single edible serving, which makes the conversation easier for new or cautious customers.
One math point worth knowing: 200 sprays at 5 mg works out to roughly 1,000 mg of THC per canister. A product that looks like a small breath spray carries a large total dose, and that should be part of every conversation with a novice buyer.
The harder questions are about onset and absorption. “Fast-acting” is the company’s claim, and the announcement does not specify whether the dose is absorbed through the lungs, the mouth or both. That detail shapes how quickly a customer feels effects, how long they last and how they should space a second spray. It is also exactly what a customer will ask.
The format also creates a storage and handling conversation. A pocket-sized canister that resembles an everyday product raises questions about child safety and accidental use at home, so staff should know what packaging and labeling come with it and be ready to explain safe storage.
Smoke-free and battery-free formats may appeal to customers who avoid vaping or combustion for health or discretion reasons. Staff should describe what the product does and stay away from presenting it as a health product.
Questions To Ask Before Stocking
What is the absorption route, and is there onset and duration data behind the “fast-acting” claim?
Are certificates of analysis available for each batch, including dose consistency across all 200 sprays?
What child-resistant packaging and warning labels does the canister carry?
What is the wholesale cost per canister and the suggested retail price?
What training materials does EasyDay provide for floor staff?
How does the CBN content in Rest & Relax appear on the label?
The Bottom Line For Buyers
Novel formats tend to sell when budtenders can explain them confidently. If EasyDay can answer those questions with documentation, the inhaler is worth a small test order with a clear sell-through target. If not, “multi-patented” alone won’t move it off the shelf, and in a market where licensed stores are trying to prove they’re the trustworthy option, an unexplained product is a liability.